EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC 4.0

Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial

Myeongseok Koh iD, Cheol Woong Choi iD, Dae Gon Ryu iD, Seung Jung Yu iD, Sung Eun Kim iD, Kyoungwon Jung iD, Bong Eun Lee iD, Moon Won Lee iD, Dong Chan Joo iD, Jin Lee iD, Ra Ri Cha iD, Sam Ryong Jee iD

Gut and Liver · 2026

DOI: 10.5009/gnl250435 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Gut and Liver, 2026. Verfasst von Myeongseok Koh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Dong-A University Hospital, Busan, Korea. Hauptthemen laut MEDLINE: Helicobacter Infections, Metronidazole, Tetracycline, Helicobacter pylori. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean College of Helicobacter and Upper Gastrointestinal Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsMetronidazoleTetracyclineHelicobacter pyloriBismuthAmoxicillinAnti-Bacterial AgentsHumansDrug Therapy, CombinationFemaleClarithromycinProspective StudiesProton Pump InhibitorsMaleMiddle AgedRepublic of KoreaDrug Resistance, BacterialAdultAgedTreatment OutcomeDrug Administration Schedule

Stichwörter der Autor:innen

Antibiotic resistanceBismuthClarithromycinEradicationHelicobacter pylori

Substanzen

MetronidazoleTetracyclineBismuthAmoxicillinClarithromycinAnti-Bacterial AgentsProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Dong-A University Hospital, Busan, Korea.
  • Department of Internal Medicine, Medical Research Institute, Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Ho…
  • Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea.
  • Department of Internal Medicine, Pusan National University Hospital, Busan, Korea.
  • Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.

ORCID-Profile: Myeongseok Koh, Cheol Woong Choi, Dae Gon Ryu, Seung Jung Yu, Sung Eun Kim, Kyoungwon Jung, Bong Eun Lee, Moon Won Lee, Dong Chan Joo, Jin Lee, Ra Ri Cha, Sam Ryong Jee

Förderung

  • Korean College of Helicobacter and Upper Gastrointestinal Research Foundation

Zitieren

APA

Koh, M., Choi, C. W., Ryu, D. G., Yu, S. J., Kim, S. E., Jung, K., Lee, B. E., Lee, M. W., Joo, D. C., Lee, J., Cha, R. R., & Jee, S. R. (2026). Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial. Gut and Liver. https://doi.org/10.5009/gnl250435

Vancouver

Koh M, Choi CW, Ryu DG, Yu SJ, Kim SE, Jung K, et al. Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial. Gut and Liver. 2026. doi:10.5009/gnl250435

BibTeX
@article{Koh2026,
  author = {Koh, Myeongseok and Choi, Cheol Woong and Ryu, Dae Gon and Yu, Seung Jung and Kim, Sung Eun and Jung, Kyoungwon and Lee, Bong Eun and Lee, Moon Won and Joo, Dong Chan and Lee, Jin and Cha, Ra Ri and Jee, Sam Ryong},
  title = {Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial},
  journal = {Gut and Liver},
  year = {2026},
  doi = {10.5009/gnl250435}
}
Kostenlos starten →